We are live on
!
Find out more
Lineage Cell Therapeutics
LCTX
LCTX
57 hedge funds and large institutions have $70M invested in Lineage Cell Therapeutics in 2014 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 19 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
6% more capital invested
Capital invested by funds: $66.3M → $70M (+$3.72M)
0.23% more ownership
Funds ownership: 37.31% → 37.54% (+0.23%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 19
8% less funds holding
Funds holding: 62 → 57 (-5)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
90% less call options, than puts
Call options by funds: $59K | Put options by funds: $575K
Holders
57
Holders Change
-5
Holders Change %
-8.06%
% of All Funds
1.65%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
19
Reduced
19
Closed
10
Calls
$59K
Puts
$575K
Net Calls
-$516K
Net Calls Change
-$321K
